Zurich Cantonal Bank’s Rigel Pharmaceuticals RIGL Stock Holding History

Zurich Cantonal Bank’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.06K	Buy	+335	New	+$11.3K	﹤0.01%	2485
2025 Q4	–	Sell	-461	Closed	-$17.4K	–	3321
2025 Q3	$13.1K	Sell	461 -202	-30%	-$6.04K	﹤0.01%	2488
2025 Q2	$12.4K	Sell	663 -73	-10%	-$1.38K	﹤0.01%	2506
2025 Q1	$13.2K	Buy	+736	New	+$14.9K	﹤0.01%	2574
2022 Q4	–	Sell	-2,669	Closed	-$31K	–	2894
2022 Q3	$31K	Hold	2,669	–	–	﹤0.01%	2722
2022 Q2	$30K	Hold	2,669	–	–	﹤0.01%	2727
2022 Q1	$80K	Sell	2,669 -1,577	-37%	-$42.7K	﹤0.01%	2375
2021 Q4	$113K	Sell	4,246 -159	-4%	-$4.8K	﹤0.01%	2442
2021 Q3	$160K	Buy	4,405 +51	+1%	+$2.01K	﹤0.01%	2068
2021 Q2	$189K	Buy	4,354 +826	+23%	+$31.2K	﹤0.01%	1847
2021 Q1	$121K	Sell	3,528 -1,627	-32%	-$64.4K	﹤0.01%	2052
2020 Q4	$180K	Buy	5,155 +4,177	+427%	+$121K	﹤0.01%	1917
2020 Q3	$23K	Hold	978	–	–	﹤0.01%	2470
2020 Q2	$18K	Hold	978	–	–	﹤0.01%	2474
2020 Q1	$15K	Hold	978	–	–	﹤0.01%	2414
2019 Q4	$21K	Hold	978	–	–	﹤0.01%	2492
2019 Q3	$18K	Hold	978	–	–	﹤0.01%	2476
2019 Q2	$26K	Hold	978	–	–	﹤0.01%	2380
2019 Q1	$25K	Sell	978 -892	-48%	-$20.4K	﹤0.01%	2351
2018 Q4	$43K	Hold	1,870	–	–	﹤0.01%	2127
2018 Q3	$60K	Buy	1,870 +605	+48%	+$18.2K	﹤0.01%	2048
2018 Q2	$36K	Buy	+1,265	New	+$45K	﹤0.01%	2287

Other funds holding RIGL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zurich Cantonal Bank's RIGL Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Rigel Pharmaceuticals (RIGL) in Q1 2026: 335 shares worth $9.06K. The stake represents ﹤0.01% of the portfolio and ranks #2485 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in RIGL as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in RIGL in Q2 2018 and has held it in 22 quarters since. The position peaked at $189K in Q2 2021. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

Zurich Cantonal Bank held 335 shares of Rigel Pharmaceuticals worth $9.06K as of Q1 2026.
Rigel Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
Rigel Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2485 holding.
Zurich Cantonal Bank first reported a position in Rigel Pharmaceuticals in Q2 2018 and has held it in 22 quarters since.
Zurich Cantonal Bank's Rigel Pharmaceuticals position peaked at $189K in Q2 2021.
159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.